GPT and metabolic dysfunction-associated steatotic liver disease: The ALT/AST ratio, FIB-4, and NAFLD fibrosis scores can reliably exclude advanced fibrosis in a high proportion of patients with NAFLD, allowing liver biopsy to be used in a more directed manner.